NCT00992420

Genotype Information and Functional Testing Study

GIFT: Genotype Information and Functional Testing Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Scripps Health · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is a sub-study of GRAVITAS (clinicaltrials.gov identifier NCT00645918). The purpose of this study is to assess which genes influence residual platelet reactivity on standard dose clopidogrel therapy, and also to determine whether certain genes influence the incremental change in platelet reactivity with high-dose clopidogrel maintenance dosing in patients who have high residual platelet reactivity on standard dosing.

Detailed description

AS DESCRIBED BY THE PI: This study is a sub-study of GRAVITAS (clinicaltrials.gov identifier NCT00645918). The purpose of this study is to assess which genes influence residual platelet reactivity on standard dose clopidogrel therapy, and also to determine whether certain genes influence the incremental change in platelet reactivity with high-dose clopidogrel maintenance dosing in patients who have high residual platelet reactivity on standard dosing.

Conditions

• Coronary Artery Disease

Timeline

• Start date: 2009-10-01
• Primary completion: 2010-08-31
• Completion: 2010-08-31
• First posted: 2009-10-09
• Last updated: 2022-11-23

Locations

1 site across 1 country: United States